Patents by Inventor Tiancheng Han

Tiancheng Han has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240060137
    Abstract: The present application provides a detection system and a detection method of genomic carcinogenesis information based on cell-free DNA, particularly plasma cell-free DNA. The system includes a library construction apparatus, a sequencing apparatus and an information analysis apparatus, the library construction apparatus is configured to convert 5-methylcytosine (5-mC) in the cell-free DNA in a to-be-detected sample into 5-formylcytosine (5-fC) and 5-carboxycytosine (5-caC) and convert non-methylated cytosine (C) into uracil (U) by using enzymes, and the information analysis apparatus is capable of analyzing methylation density of genome, fragment size distribution, fragment 5? end motif and/or chromosome stability. With the adoption of the system and the method, early, sensitive and accurate detection and screening of various cancers can be synchronously implemented.
    Type: Application
    Filed: November 2, 2022
    Publication date: February 22, 2024
    Inventors: Yulong LI, Yuanyuan HONG, Tiancheng HAN, Fang LV, Shunli YANG, Peiyao NIE, Qi ZHANG, Weizhi CHEN
  • Publication number: 20220228209
    Abstract: Embodiments of the invention provides methods for determining a methylation score of DNA and determining a ctDNA Fraction (CTDF) value. Additional embodiments are as described herein.
    Type: Application
    Filed: September 30, 2021
    Publication date: July 21, 2022
    Applicants: Genecast Biotechnology Co., Ltd., Genecast (Beijing) Biotechnology Co., Ltd., Genecast (Wuxi) Precision Medicine Diagnostic Laboratory Co., Ltd.
    Inventors: Tiancheng Han, Xiaofeng Song, Jianing Yu, Yuanyuan Hong, Weizhi Chen, Bo Du